AR and hepatocellular carcinoma: In prostate cancer cells, similar interactions between AR and STAT5a/b signaling were shown (59) and in hepatocellular cancer, CBG expression is regulated via the pioneer factors FOXA1 and the estrogen receptor, potentially underlying sex differences in CBG (60).